About 6 M people in Europe suffer from Atrial Fibrillation (AF), the most common cardiac arrhythmia, a heart condition that causes an irregular heart rate. AF doubles the risk of all-cause mortality and a worsened Quality of Life. By 2050, 2% of the world population will be affected by this condition. The highly effective treatment of AF is ablation. However, a precise diagnosis comes first. Only with a detailed diagnosis can we stratify AF patients precisely and give them the best treatment.
This webinar is the first event about AF which brings together investigators, policy makers, industry and patients associations to discuss about the AF. Civil society has the power to influence behaviour and decision making by individuals and by organisations and institutions that are involved.
Objectives
Discuss the relevance of stratifying patients to obtain a better diagnosis of AF.
Present to the audience the different projects and their aims.
Establish future collaboration channels between the participants.
Addressed to
Researchers and clinicians;
Policy makers and industry;
General public and patients associations.
Where and When
Subscription
REGISTER NOW!